Open Access Research
暂无分享,去创建一个
T. Goldmann | E. Vollmer | H. Schultz | D. Drömann | S. Marwitz | K. Röschmann | K. Rohmann | Sinia Osbahr | K. Dalhoff | Mahdi Abdullah | Torsten Goldmann | Jan Rupp | Artur J Ulmer | Peter Zabel | Ekkehard Vollmer | Klaus Dalhoff | Jan Rupp | Artur J Ulmer
[1] J. Riordan,et al. Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures. , 2010, American journal of physiology. Lung cellular and molecular physiology.
[2] P. Barnes,et al. The cytokine network in chronic obstructive pulmonary disease. , 2009, American journal of respiratory cell and molecular biology.
[3] Mustafa Ozen,et al. Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer , 2009, Clinical Cancer Research.
[4] T. Murphy,et al. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.
[5] N. White,et al. cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[6] T. Ha,et al. Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. , 2008, Biochemical and biophysical research communications.
[7] T. Goldmann,et al. TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens , 2008, Diagnostic Pathology.
[8] R. Strieter. What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. , 2008, Proceedings of the American Thoracic Society.
[9] T. Kelley,et al. Electrochemical analysis of cell plasma membrane cholesterol at the airway surface of mouse trachea. , 2008, Analytical chemistry.
[10] R. Stockley,et al. The interaction of host and pathogen factors in chronic obstructive pulmonary disease exacerbations and their role in tissue damage. , 2007, Proceedings of the American Thoracic Society.
[11] Jonathan D. Smith,et al. Direct electrochemical evaluation of plasma membrane cholesterol in live mammalian cells. , 2007, Journal of the American Chemical Society.
[12] B. Grant,et al. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[13] Y. Lan,et al. The TGF‐β pseudoreceptor gene Bambi is dispensable for mouse embryonic development and postnatal survival , 2007, Genesis.
[14] E. Mazzon,et al. Protective effect of orally administered carnosine on bleomycin-induced lung injury. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[15] T. Goldmann,et al. Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[16] N. White,et al. Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[17] A. Verkman,et al. CFTR inhibition mimics the cystic fibrosis inflammatory profile. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[18] A. Churg,et al. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. , 2006, American journal of respiratory and critical care medicine.
[19] D. Warburton,et al. Smad3 signaling involved in pulmonary fibrosis and emphysema. , 2006, Proceedings of the American Thoracic Society.
[20] D. Sheppard,et al. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. , 2006, Proceedings of the American Thoracic Society.
[21] R. Homer,et al. Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. , 2006, Proceedings of the American Thoracic Society.
[22] John R. Riordan,et al. Misassembled mutant ΔF508 CFTR in the distal secretory pathway alters cellular lipid trafficking , 2006, Journal of Cell Science.
[23] Dechen Jiang,et al. Enzyme modification of platinum microelectrodes for detection of cholesterol in vesicle lipid bilayer membranes. , 2005, Analytical chemistry.
[24] T. Flotte,et al. The Short Apical Membrane Half-life of Rescued ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Results from Accelerated Endocytosis of ΔF508-CFTR in Polarized Human Airway Epithelial Cells* , 2005, Journal of Biological Chemistry.
[25] T. Goldmann,et al. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients , 2005, Respiratory research.
[26] M. Schluchter,et al. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[27] T. Steck,et al. How cholesterol homeostasis is regulated by plasma membrane cholesterol in excess of phospholipids. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Roberts,et al. Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-β-Mediated Pulmonary Fibrosis1 , 2004, The Journal of Immunology.
[29] N. White,et al. Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C. , 2004, American journal of respiratory cell and molecular biology.
[30] T. Goldmann,et al. Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection. , 2004, FEMS immunology and medical microbiology.
[31] J. Riordan,et al. Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. , 2004, Molecular biology of the cell.
[32] L. Liscum,et al. The Transport of Low Density Lipoprotein-derived Cholesterol to the Plasma Membrane Is Defective in NPC1 Cells* , 2003, The Journal of Biological Chemistry.
[33] T. Goldmann,et al. Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung , 2003, Histochemistry and Cell Biology.
[34] Hong Yang,et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. , 2002, The Journal of clinical investigation.
[35] M. Broncel,et al. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia , 2002, European Journal of Clinical Pharmacology.
[36] B. Grant,et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. , 2002, The New England journal of medicine.
[37] B. Grant,et al. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.
[38] P. A. Peterson,et al. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. , 2000, The American journal of pathology.
[39] A. Vaughan,et al. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. , 2000, Current opinion in lipidology.
[40] S. Sethi. Bacterial infection and the pathogenesis of COPD. , 2000, Chest.
[41] J. Hasday,et al. Bacterial endotoxin is an active component of cigarette smoke. , 1999, Chest.
[42] W. Timens,et al. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[43] P. Davis,et al. Overexpression of R domain eliminates cAMP-stimulated Cl- secretion in 9/HTEo- cells in culture. , 1996, The American journal of physiology.
[44] S. Swain,et al. Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion , 1995, The Journal of experimental medicine.
[45] E. Bleecker,et al. Altered cytokine regulation in the lungs of cigarette smokers. , 1994, American journal of respiratory and critical care medicine.
[46] Michael J. Hartshorn,et al. Structural model of ATP-binding proteing associated with cystic fibrosis, multidrug resistance and bacterial transport , 1990, Nature.
[47] O. Baskurt,et al. Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties. , 2007, Clinical hemorheology and microcirculation.
[48] P. Keeling,et al. The dinoflagellates Durinskia baltica and Kryptoperidinium foliaceum retain functionally overlapping mitochondria from two evolutionarily distinct lineages , 2007, BMC Evolutionary Biology.
[49] R. Schwabe,et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. , 2007, Nature medicine.
[50] M. Ameloot,et al. Membrane cholesterol extraction decreases Na+ transport in A6 renal epithelia. , 2006, American journal of physiology. Cell physiology.
[51] A. Verkman,et al. In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents. , 2005, Journal of pharmaceutical sciences.
[52] J. Keski‐Oja,et al. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. , 2004, Critical reviews in clinical laboratory sciences.
[53] T. Akiyama,et al. Transcriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signaling. , 2004, Biochemical and biophysical research communications.
[54] H. Scherthan,et al. HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. , 2001, Pathology, research and practice.
[55] C. Niehrs,et al. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. , 1999, Nature.
[56] A. Roberts,et al. Regulation of immune responses by TGF-beta. , 1998, Annual review of immunology.
[57] L. Tsui,et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.